The B domain of protein A retains residual structures in 6 M guanidinium chloride as revealed by hydrogen/deuterium‐exchange NMR spectroscopy
Protein Science · 2023
DOI: 10.1002/pro.4569 ↗At a glance
Journal article in Protein Science, 2023. Written by Saeko Yanaka and 3 co-authors. Institution: Exploratory Research Center on Life and Living Systems (ExCELLS) and Institute for Molecular Science (IMS), National Institutes of Natural Sciences, …. Major MEDLINE topics: Hydrogen, Protons. Cited 3 times so far (Crossref); 81 references. The full text is freely available (open access, CC BY 4.0). Funded by: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Institute for Molecular Science.
Abstract (original language)
The characterization of residual structures persistent in unfolded proteins is an important issue in studies of protein folding, because the residual structures present, if any, may form a folding initiation site and guide the subsequent folding reactions. Here, we studied the residual structures of the isolated B domain (BDPA) of staphylococcal protein A in 6 M guanidinium chloride. BDPA is a small three‐helix‐bundle protein, and until recently its folding/unfolding reaction has been treated as a simple two‐state process between the native and the fully unfolded states. We employed a dimethylsulfoxide (DMSO)‐quenched hydrogen/deuterium (H/D)‐exchange 2D NMR techniques with the use of spin desalting columns, which allowed us to investigate the H/D‐exchange behavior of individually identified peptide amide (NH) protons. We obtained H/D‐exchange protection factors of the 21 NH protons that form an α‐helical hydrogen bond in the native structure, and the majority of these NH protons were significantly protected with a protection factor of 2.0–5.2 in 6 M guanidinium chloride, strongly suggesting that these weakly protected NH protons form much stronger hydrogen bonds under native folding conditions. The results can be used to deduce the structure of an early folding intermediate, when such an intermediate is shown by other methods. Among three native helical regions, the third helix in the C‐terminal side was highly protected and stabilized by side‐chain salt bridges, probably acting as the folding initiation site of BDPA. The present results are discussed in relation to previous experimental and computational findings on the folding mechanisms of BDPA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Exploratory Research Center on Life and Living Systems (ExCELLS) and Institute for Molecular Science (IMS), National Institutes of Natural Sciences, Myodaiji, Okazaki, Aichi, Japan.
- Department of Functional Molecular Science, School of Physical Sciences, SOKENDAI (the Graduate University for Advanced Studies), Myodaiji, Okazaki, Aichi, Japan.
- Graduate School of Pharmaceutical Sciences, Nagoya City University, Mizuho-ku, Nagoya, Aichi, Japan.
- Department of Physics, School of Science, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
ORCID profiles: Saeko Yanaka, Maho Yagi-Utsumi, Koichi Kato, Kunihiro Kuwajima
Funding
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- Institute for Molecular Science
Cite
APA
Yanaka, S., Yagi-Utsumi, M., Kato, K., & Kuwajima, K. (2023). The B domain of protein A retains residual structures in 6 M guanidinium chloride as revealed by hydrogen/deuterium‐exchange NMR spectroscopy. Protein Science. https://doi.org/10.1002/pro.4569
Vancouver
Yanaka S, Yagi-Utsumi M, Kato K, Kuwajima K. The B domain of protein A retains residual structures in 6 M guanidinium chloride as revealed by hydrogen/deuterium‐exchange NMR spectroscopy. Protein Science. 2023. doi:10.1002/pro.4569
BibTeX
@article{Yanaka2023,
author = {Yanaka, Saeko and Yagi-Utsumi, Maho and Kato, Koichi and Kuwajima, Kunihiro},
title = {The B domain of protein A retains residual structures in 6 M guanidinium chloride as revealed by hydrogen/deuterium‐exchange NMR spectroscopy},
journal = {Protein Science},
year = {2023},
doi = {10.1002/pro.4569}
}
EUVIMED